Loading…
Viemed Healthcare, Inc. is projected to rise to $13.83 by 2027, a +40% move from its current price of $9.89. VMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.68 | $9.89 | $10.11 | +0.04% |
| May 30 | $9.60 | $9.90 | $10.20 | +0.08% |
| May 31 | $9.54 | $9.90 | $10.27 | +0.11% |
| Jun 1 | $9.49 | $9.90 | $10.34 | +0.15% |
| Jun 2 | $9.45 | $9.91 | $10.39 | +0.19% |
| Jun 3 | $9.41 | $9.91 | $10.44 | +0.23% |
| Jun 4 | $9.37 | $9.92 | $10.49 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.37 | $9.92 | $10.49 | +0.27% |
| Week 2 | $9.18 | $9.94 | $10.77 | +0.53% |
| Week 3 | $9.04 | $9.97 | $10.99 | +0.80% |
| Week 4 | $8.93 | $10.00 | $11.19 | +1.07% |
| Week 5 | $8.83 | $10.02 | $11.37 | +1.33% |
| Week 6 | $8.75 | $10.05 | $11.54 | +1.60% |
| Week 7 | $8.68 | $10.08 | $11.70 | +1.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company offers respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services.
Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Viemed Healthcare, Inc. (VMD) trades in the Healthcare sector with a current price of $9.65 and a market capitalization of $369.95M, ranking 3306 by market size. The stock’s near-term technical context shows momentum patterns consistent with a bullish stance, while the latest price sits above key moving averages.
The stock is currently trading near the 50-day moving average (SMA50) at $9.49 and above the 200-day moving average (SMA200) at $7.81, with RSI14 at 50. This places the price in a constructive frame against longer-term trend lines while volatility remains a consideration.
Key support and resistance levels are indicated at $8.52 and $10.05 respectively, with a 30-day price range of $8.35 to $11.15. The stock’s annualized volatility is listed at 40%, signaling meaningful price fluctuation over time. Looking ahead, a multi-year forecast shows upside potential with elevated average prices and ROIs across decades, starting from 2026 through 2050.
A major floor 26.2% below — a decisive break under it would weaken the trend.
The nearest floor, 13.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.6% away) — a breakout level to watch.
A major ceiling 11.4% above — clearing it would confirm fresh momentum.
Key VMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.69 | Buy | $9.70 | Buy |
| MA 10 | $9.61 | Buy | $9.62 | Buy |
| MA 20 | $9.51 | Buy | $9.56 | Buy |
| MA 50 | $9.50 | Buy | $9.36 | Buy |
| MA 100 | $8.81 | Buy | $8.89 | Buy |
| MA 200 | $7.84 | Buy | $8.28 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.58 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 95.63 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 10.63 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 78.81 | Sell |
| Momentum (10) | 0.53 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 9.74 | Buy |
| ADX (14) | 9.95 | Neutral |
| ATR (14) | 0.18 | Info |
The near-term technical picture is bullish, with RSI14 at 50. The stock is trading around its SMA50 of $9.49 and above its SMA200 of $7.81, suggesting price strength against a longer-term trend. Near-term momentum remains a key focus, supported by a baseline bullish sentiment.
The 30-day range spans from $8.35 to $11.15, and the stock has a stated support level at $8.52 and a resistance level at $10.05. With annualized volatility at 40%, upside moves may come with meaningful risk, so traders may monitor these levels as price action evolves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.22 | $9.89 | $13.78 | 0% | Neutral | |
| $11.20 | $13.83 | $17.95 | +40% | Bullish | |
| $14.12 | $17.80 | $23.76 | +80% | Bullish | |
| $17.40 | $22.31 | $30.48 | +126% | Bullish | |
| $19.42 | $25.29 | $35.23 | +156% | Bullish | |
| $21.53 | $28.43 | $40.29 | +187% | Bullish | |
| $23.65 | $31.63 | $45.53 | +220% | Bullish | |
| $25.48 | $34.48 | $50.34 | +249% | Bullish | |
| $32.47 | $44.45 | $65.74 | +349% | Bullish | |
| $38.12 | $52.75 | $78.97 | +433% | Bullish | |
| $55.59 | $80.78 | $127.28 | +717% | Bullish | |
| $119.54 | $188.57 | $320.49 | +18.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.22 | $9.89 | $11.56 | +0.00% |
| June 2026 | $8.46 | $9.89 | $11.79 | -0.04% |
| July 2026 | $8.70 | $10.24 | $12.34 | +3.55% |
| August 2026 | $8.79 | $10.40 | $12.64 | +1.59% |
| September 2026 | $8.71 | $10.35 | $12.66 | -0.50% |
| October 2026 | $8.93 | $10.65 | $13.11 | +2.88% |
| November 2026 | $9.26 | $11.07 | $13.70 | +4.00% |
| December 2026 | $9.23 | $11.08 | $13.78 | +0.05% |
Click any year to see its month-by-month VMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VMD is projected to trade between $7.22 and $13.78, averaging $9.89 — a potential gain of 0% from today's $9.89. Price action looks broadly range-bound.
Viemed Healthcare, Inc.'s 2027 outlook centres on $13.83, within a $11.20 to $17.95 range. That is up +40% on the projected 2026 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, VMD could reach as high as $23.76, with a base case around $17.80 and support toward $14.12 — roughly +80% from $9.89. Momentum favours further upside here.
Expect VMD to range from $17.40 to $30.48 through 2029. The $22.31 average target implies a +126% move from current prices. That is up +25% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The VMD price prediction for 2030 points to an average of $25.29 (low $19.42, high $35.23) — a potential gain of +156% on today's $9.89. Momentum favours further upside here.
In 2031, VMD is projected to trade between $21.53 and $40.29, averaging $28.43 — a potential gain of +187% from today's $9.89. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Viemed Healthcare, Inc.'s 2032 outlook centres on $31.63, within a $23.65 to $45.53 range. That is up +11% on the projected 2031 average. That marks a +220% change versus current levels. Momentum favours further upside here.
By 2033, VMD could reach as high as $50.34, with a base case around $34.48 and support toward $25.48 — roughly +249% from $9.89. Buyers look set to stay in control over this stretch.
Expect VMD to range from $32.47 to $65.74 through 2034. The $44.45 average target implies a +349% move from current prices. That is up +29% on the projected 2033 average. Momentum favours further upside here.
The VMD price prediction for 2035 points to an average of $52.75 (low $38.12, high $78.97) — a potential gain of +433% on today's $9.89. Buyers look set to stay in control over this stretch.
In 2040, VMD is projected to trade between $55.59 and $127.28, averaging $80.78 — a potential gain of +717% from today's $9.89. That is up +53% on the projected 2035 average. Momentum favours further upside here.
Viemed Healthcare, Inc.'s 2050 outlook centres on $188.57, within a $119.54 to $320.49 range. That is up +133% on the projected 2040 average. That marks a +18.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in VMD today (≈ 101.112235 VMD) could be worth
$19,066.68
+$18,066.68 (+1807%) by 2050 · US Dollar
Based on the average projected VMD price of $188.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VMDwould be worth at today's price.
$1,000 invested in VMD on May 27, 2025 (≈ 151.515154 VMD) would be worth
$1,498.48
+$498.48 (+49.8%) today · 1.50× · US Dollar
Based on a VMD entry price of $6.6 vs. today's $9.89.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.68 | $1,021.69 | +2.2% |
| 1 month ago | $9.88 | $1,001.01 | +0.1% |
| 3 months ago | $8.6 | $1,150 | +15.0% |
| 6 months ago | $6.91 | $1,431.26 | +43.1% |
| 1 year ago | $6.6 | $1,498.48 | +49.8% |
| All time (5.0y) ago | $7.19 | $1,375.52 | +37.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VMD forecast.
Our base-case forecast reaches $20.00 around 2029.
Implied market cap at $20.00: $766.74M
The multi-year forecast presents a clear upside trajectory. In 2026 the avg price is $9.65 with a min of $7.22 and a max of $13.46, and ROI of 0 with a Neutral sentiment. The outlook improves in subsequent years, with 2027 avg $13.61 (ROI 41) and 2028 avg $17.50 (ROI 81.3), followed by 2029 avg $21.83 (ROI 126.3) and 2030 avg $24.93 (ROI 158.4).
By 2031 the avg is $27.91 (ROI 189.2), 2032 $30.96 (ROI 220.8), 2033 $34.15 (ROI 253.9), 2034 $43.86 (ROI 354.5), and 2035 $51.78 (ROI 436.6). The forecast extends to 2040 with an avg of $79.85 (ROI 727.4) and to 2050 with an avg of $185.42 (ROI 1821.4), both indicated as bullish.
These estimates imply substantial upside potential over the long term, but they are not guarantees and depend on market conditions and other factors. Investors should consider the forecast as one reference point among many, recognizing that outcomes can vary and that estimates may not reflect actual future performance.
Tap a question to reveal the answer.
In 2030, the forecast shows an avg price of $24.93 with a max of $34.91 and a min of $19.07; ROI 158.4%; sentiment BULLISH.
The long-term forecast shows bullish sentiment from 2027 onward with rising avg prices; for 2026 the forecast is NEUTRAL with avg $9.65 and ROI 0.
The forecast shows 2033 max $50.15 and 2034 max $65.27, indicating that a value around $50 is within the forecast path.
The 30-day range is $8.35 to $11.15; support $8.52; resistance $10.05; RSI14 is 50; SMA50 is $9.49; SMA200 is $7.81; current price is $9.65 with bullish sentiment.
Current price $9.65; market cap $369.95M.
Viemed Healthcare, Inc. Community Discussion
0Share your Viemed Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.